S. Ozturk Et Al. , "INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS," ACTA MEDICA MEDITERRANEA , vol.37, no.5, pp.2593-2597, 2021
Ozturk, S. Et Al. 2021. INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS. ACTA MEDICA MEDITERRANEA , vol.37, no.5 , 2593-2597.
Ozturk, S., Kant, A., Comoglu, S., Ertunc, B., & YILMAZ, G., (2021). INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS. ACTA MEDICA MEDITERRANEA , vol.37, no.5, 2593-2597.
Ozturk, Sinan Et Al. "INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS," ACTA MEDICA MEDITERRANEA , vol.37, no.5, 2593-2597, 2021
Ozturk, Sinan Et Al. "INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS." ACTA MEDICA MEDITERRANEA , vol.37, no.5, pp.2593-2597, 2021
Ozturk, S. Et Al. (2021) . "INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS." ACTA MEDICA MEDITERRANEA , vol.37, no.5, pp.2593-2597.
@article{article, author={Sinan Ozturk Et Al. }, title={INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS}, journal={ACTA MEDICA MEDITERRANEA}, year=2021, pages={2593-2597} }